AD + EA (n = 10) | AD + no EA (n = 12) | no AD (n = 34) | |
---|---|---|---|
Test trials | |||
SOC/ALC | 701.24 (36.28) | 838.46 (45.36) | 749.97 (28.21) |
PHYS/ALC | 719.77 (44.39) | 865.97 (51.78) | 744.80 (27.10) |
Baseline trials | |||
NEU/ALC | 703.34 (38.74) | 845.49 (55.22) | 739.24 (25.33) |
SOC/NEU | 701.25 (37.25) | 805.86 (44.91) | 738.97 (30.76) |
PHYS/NEU | 697.30 (41.01) | 805.24 (48.24) | 716.62 (24.26) |